Quidel (QDEL) Sees Record Quarterly Results Due To Demand For Flu Tests
QDEL Hot Sheet
Financial Fact:Research and development: 8.5M
Today's EPS Names:
TARO, BRLI, TLB, More
After the close, Quidel Corporation (NASDAQ: QDEL) announced today that it currently anticipates its highest quarterly revenue and operating income in its history, driven by global shipments of its QuickVue(R) Influenza A+B tests in the third quarter of 2009.
Quidel said demand for its market-leading tests accelerated during the third quarter, consistent with reports of escalating influenza-like illness in the U.S.
Since the end of April 2009, the company has continued to manufacture flu tests seven days a week at its facility in San Diego and has the capacity to produce millions of additional tests per month to accommodate customer orders.
Shares of QDEL are up 4.9% in pre-open trading today.
Quidel said demand for its market-leading tests accelerated during the third quarter, consistent with reports of escalating influenza-like illness in the U.S.
Since the end of April 2009, the company has continued to manufacture flu tests seven days a week at its facility in San Diego and has the capacity to produce millions of additional tests per month to accommodate customer orders.
Shares of QDEL are up 4.9% in pre-open trading today.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- UPDATE: NetApp, Inc. (NTAP) Tops Q4 EPS by 3c; Guides Q1 Lower
- Vodafone (VOD) Volatility Pops Early, Shares Inch Higher
Create E-mail Alert Related Categories
Guidance, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
